Skip to main content
. 2015 Aug 17;33(33):3880–3886. doi: 10.1200/JCO.2015.61.7779

Table 3.

Performance of DAS in the Validation Set

graphic file with name zlj03315-5524-t03.jpg

Variable P AUC 95% CI
Total < .001 0.650 0.585 to 0.716
Sex
    Female .3057 0.563 0.434 to 0.692
    Male < .001 0.692 0.620 to 0.765
Smoking status
    Current smoker < .001 0.652 0.569 to 0.735
    Former smoker .0151 0.644 0.537 to 0.750
Histology
    Adenocarcinoma .3084 0.557 0.448 to 0.667
    SCC .0063 0.658 0.547 to 0.769
    Other NSCLC < .001 0.754 0.643 to 0.865
Stage
    I and II .0124 0.675 0.546 to 0.804
    III and IV < .001 0.693 0.613 to 0.773
Timing of blood draw, months
    0-6 < .001 0.740 0.634 to 0.846
    > 6-12 .0409 0.588 0.505 to 0.671

Abbreviations: AUC, area under the curve; DAS, N1,N12-diacetylspermine; NSCLC, non–small-cell lung cancer; SCC, squamous cell carcinoma.